JP2012506442A5 - - Google Patents

Download PDF

Info

Publication number
JP2012506442A5
JP2012506442A5 JP2011533273A JP2011533273A JP2012506442A5 JP 2012506442 A5 JP2012506442 A5 JP 2012506442A5 JP 2011533273 A JP2011533273 A JP 2011533273A JP 2011533273 A JP2011533273 A JP 2011533273A JP 2012506442 A5 JP2012506442 A5 JP 2012506442A5
Authority
JP
Japan
Prior art keywords
scar
adhesion
existing
use according
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011533273A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012506442A (ja
JP5785085B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/061345 external-priority patent/WO2010065206A1/en
Publication of JP2012506442A publication Critical patent/JP2012506442A/ja
Publication of JP2012506442A5 publication Critical patent/JP2012506442A5/ja
Application granted granted Critical
Publication of JP5785085B2 publication Critical patent/JP5785085B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011533273A 2008-10-20 2009-10-20 癒着を処置又は防止するためのポリペプチド Expired - Fee Related JP5785085B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10683408P 2008-10-20 2008-10-20
US61/106,834 2008-10-20
PCT/US2009/061345 WO2010065206A1 (en) 2008-10-20 2009-10-20 Polypeptide for treating or preventing adhesions

Publications (3)

Publication Number Publication Date
JP2012506442A JP2012506442A (ja) 2012-03-15
JP2012506442A5 true JP2012506442A5 (https=) 2012-12-06
JP5785085B2 JP5785085B2 (ja) 2015-09-24

Family

ID=42108870

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011533273A Expired - Fee Related JP5785085B2 (ja) 2008-10-20 2009-10-20 癒着を処置又は防止するためのポリペプチド

Country Status (11)

Country Link
US (1) US9034815B2 (https=)
EP (1) EP2349310B1 (https=)
JP (1) JP5785085B2 (https=)
KR (2) KR20170001756A (https=)
CN (1) CN102256613B (https=)
AU (1) AU2009322865B2 (https=)
BR (1) BRPI0919759A2 (https=)
CA (1) CA2741302C (https=)
DK (1) DK2349310T3 (https=)
ES (1) ES2507496T3 (https=)
WO (1) WO2010065206A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2617431T3 (en) 2007-01-10 2017-07-10 Purdue Research Foundation Polypeptide inhibitors of HSP27 kinase and applications therefor
WO2009021137A2 (en) * 2007-08-07 2009-02-12 Purdue Research Foundation Kinase inhibitors and uses thereof
EP2378875B1 (en) * 2008-12-10 2018-05-30 Purdue Research Foundation Cell-permeant peptide-based inhibitor of kinases
US9890195B2 (en) * 2009-07-27 2018-02-13 Purdue Research Foundation MK2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
US20130115256A1 (en) * 2010-05-24 2013-05-09 Cynthia Lander Methods for treating or preventing vascular graft failure
KR101862291B1 (ko) 2011-04-12 2018-05-29 모레 매트릭스 인코포레이티드 이상 섬유모세포 증식 및 세포외 기질 침착을 특징으로 하는 질병, 질환, 또는 과정을 예방하거나 치료하기 위한 조성물 및 방법
US9890200B2 (en) 2011-04-12 2018-02-13 Moerae Matrix, Inc. Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
WO2013134636A1 (en) 2012-03-09 2013-09-12 Purdue Research Foundation Compositions and methods for delivery of kinase inhibiting peptides
ES2991989T3 (es) * 2012-03-23 2024-12-05 Macro Biologics Inc Composiciones y usos de materiales antimicrobianos con propiedades compatibles con tejidos
US20140072613A1 (en) * 2012-09-10 2014-03-13 Cynthia Lander Compositions and Methods for Treating Cutaneous Scarring
WO2016061145A1 (en) * 2014-10-13 2016-04-21 Symic Biomedical, Inc. Synthetic proteoglycans for preventing tissue adhesion
JP2018501201A (ja) * 2014-11-17 2018-01-18 モイライ マトリックス インコーポレイテッド 異常な線維芽細胞増殖および細胞外マトリックス沈着を特徴とする疾患、状態、またはプロセスを予防または処置するための組成物および方法
WO2016112292A1 (en) * 2015-01-08 2016-07-14 Moerae Matrix, Inc. Formulation of mk2 inhibitor peptides
RU2017135072A (ru) 2015-03-12 2019-04-10 Мори Матрикс, Инк. Применение пептидсодержащих композиций ингибитора mk2 для лечения немелкоклеточного рака легкого
US11285189B2 (en) 2017-04-06 2022-03-29 Amicrobe, Inc. Compositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safety
RU2741247C1 (ru) * 2020-10-13 2021-01-22 федеральное государственное бюджетное образовательное учреждение высшего образования "Ростовский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО РостГМУ Минздрава России) Способ профилактики перитонеальных спаек женского таза

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1521000A (en) * 1975-06-13 1978-08-09 Syntex Puerto Rico Inc Inhalation device
US4192309A (en) * 1978-09-05 1980-03-11 Syntex Puerto Rico, Inc. Inhalation device with capsule opener
US4227522A (en) * 1978-09-05 1980-10-14 Syntex Puerto Rico, Inc. Inhalation device
US4778054A (en) * 1982-10-08 1988-10-18 Glaxo Group Limited Pack for administering medicaments to patients
DK172541B1 (da) * 1982-10-08 1998-12-07 Glaxo Group Ltd Apparat til administrering af medikamenter til patienter og en medikamentpakning til brug i apparatet
DE3682457D1 (de) * 1985-07-30 1991-12-19 Glaxo Group Ltd Geraet zur verabreichung von medikamenten an patienten.
JPH05963A (ja) 1990-04-13 1993-01-08 Toray Ind Inc ポリペプチド類組成物
JPH07506252A (ja) 1992-04-24 1995-07-13 エス・アール・アイ・インターナシヨナル 真核細胞内でのイン・ビボ相同配列ターゲッティング
US6582728B1 (en) * 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
EP0733059B1 (en) * 1993-12-09 2000-09-13 Thomas Jefferson University Compounds and methods for site-directed mutations in eukaryotic cells
WO2003084481A2 (en) * 2002-04-01 2003-10-16 Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Arizona State University Biological affinity based delivery systems
WO2006071456A2 (en) * 2004-12-02 2006-07-06 The University Of North Carolina At Chapel Hill Inhibition of hsp27 phosphorylation for treatment of blistering disorders
CA2601823C (en) * 2005-04-15 2016-01-12 University Of Arizona Therapeutic peptides for the treatment of metastatic cancer
DK2617431T3 (en) * 2007-01-10 2017-07-10 Purdue Research Foundation Polypeptide inhibitors of HSP27 kinase and applications therefor
US20080293640A1 (en) * 2007-01-10 2008-11-27 Arizona Board of Regents, A body Corporate, of the State of Arizona, acting for and on behalf of Polypeptide inhibitors of HSP27 kinase and uses therefor
WO2008109794A2 (en) * 2007-03-08 2008-09-12 Tufts Medical Center The role of the mk2 pathway in treating fibrosis and scarring
WO2009021137A2 (en) * 2007-08-07 2009-02-12 Purdue Research Foundation Kinase inhibitors and uses thereof
WO2009123759A2 (en) * 2008-04-02 2009-10-08 Moerae Matrix, Inc. Therapeutic uses of biocompatible biogel compositions

Similar Documents

Publication Publication Date Title
JP2012506442A5 (https=)
US6506731B1 (en) Elastin peptide analogs and methods of using same
US7786084B2 (en) Treatment of burns
JP5384342B2 (ja) 癌のような変更された細胞遊走に関連する障害の治療のための薬理学的活性を有するペプチド
AU2007342674B2 (en) Polypeptide inhibitors of HSP27 kinase and uses therefor
CN104487081B (zh) 用于预防或治疗恶病质的组合物
US7803757B2 (en) Peptides based on the sequence of human lactoferrin and their use
EP2402369A2 (en) Peptide fragments for inducing synthesis of extracellular matrix proteins
JP2019104768A (ja) 代謝性症候群を予防し又は治療するための方法
EA035733B1 (ru) Пептидные ингибиторы рецептора интерлейкина-23 и их применение для лечения воспалительных заболеваний
JP2011518179A5 (https=)
JP2019533722A5 (https=)
RU2699712C1 (ru) Антимикробный пептид и его применение
RU2012136530A (ru) Новые соединения, влияющие на пищевое поведение
JP2020507623A5 (https=)
WO2017101144A1 (zh) 脂肪组织靶向多肽及其制备方法和应用
CN108530527B (zh) 一种多肽oa-gl21及其提纯方法与应用
Saklani et al. Laminin mimetic angiogenic and collagen peptide hydrogel for enhance dermal wound healing
JP2008526935A5 (https=)
JP6548126B2 (ja) Iii型コラーゲン産生促進剤
EP1392346A2 (en) Composition and method for enhancing elasticity of tissue
JP2016520592A (ja) マルファン症候群および関連障害の処置におけるアンジオテンシンペプチド
RU2458069C2 (ru) Выделенный пептид для усиления ранозаживляющей активности кератиноцитов, композиция для заживления ран у млекопитающего и лекарственное средство для применения при заживлении ран у млекопитающего
RU2010128602A (ru) Циклический белок, не содержащий остатков цистеина
CA2703894A1 (en) New synthetic arginine substituted peptides and their use